||
Share:

Exciting innovation in robotic surgery

Ground-breaking new surgical technology has taken a step closer to reality, thanks to a new partnership.

Cambridge Design Partnership (CDP) has teamed up with Canadian based Titan Medical (titanmedicalinc.com) to develop an innovative robotic surgery system. They aim to offer minimally invasive surgery (MIS) through a single incision, rather than several incisions, which is currently the case with both traditional laparoscopic surgery and existing multi-port robotic systems.

The innovative “single-port” robotic surgery system should offer swifter recovery time and less scarring for patients, in addition to better access to narrow spaces for surgeons.

“We are delighted to be working with Titan Medical on this important project,” says CDP partner Jez Clements. “It’s an exciting technology and one we are proud to be involved with.”

Technology and product innovation company CDP first started working with Titan Medical on its robotic surgery system in 2019. The collaboration has been so effective that the two companies have announced an ongoing working partnership for the project.

“We are pleased to announce our expanded collaboration with Cambridge Design Partnership,” says David McNally, President and CEO of Titan. “Since engaging with them only a few months ago, their highly qualified engineers have rapidly driven innovation and delivered significant performance improvements.”

The two companies are now working together on the single-port robotic surgical system towards a submission for FDA approval in the US.

“This technology will mean less invasive procedures for patients, offering improved recovery and less trauma,” explains Hans Pflaumer, senior mechanical engineer at CDP. “However, for a surgeon to achieve a good result with just a single small incision creates all sorts of technical and design challenges, which we have worked intensively to overcome. In the Titan robot, this is accomplished using a single 25mm port which is used to pass a 2D camera, a 3D camera and the multi-articulating instruments into the surgical site.”

CDP has its HQ in Cambridge in the UK but also has a base in Raleigh, North Carolina to better serve our clients in the US. “It has been advantageous for our team to be able to work on this project in both the US and UK time zones, effectively giving us a fifteen-hour working day,” says Hans. “As a consequence, we have been able to deliver significant design improvements in a short space of time.”

Titan’s robotic surgery technology contains a large amount of intellectual property (IP), with 47 issued and 87 pending patents on individual elements within the system. “It is a very valuable portfolio,” says senior mechanical engineer Aki Laakso. “We want to make sure Titan is maximising the impact of their IP.

“We are working on surgical instruments with multiple functions, including cutting, suturing and cauterising. We need to make all these processes as robust and stable as possible for the surgeon, while offering the best possible workspace within the patient.”

The project plays to CDP’s skills in terms of electromechanical medical device design, says CDP partner Jez Clements: “Much of the focus with Titan has been on achieving milestones in a very swift, performance-based collaboration. Titan needed results and we have been able to provide smart design decisions in a short timeframe, thanks to our skilled team and fast-paced work ethos.”

Using a multi-continental work cycle in both CDP’s UK and US bases, the team has made fast progress to overcome design challenges. “Our wealth of experience working on ISO 13485 and FDA medical device approvals stood us in good stead to work with Titan on this project,” says Jez Clements. “It’s a design-critical build which will ultimately revolutionise minimally invasive surgery. In addition, we have been able to maximise value and look at reducing costs within the design, which will help its launch onto the market.

“Ultimately, we are aiming for surgeons to use this equipment with complete confidence in the operating theatre. The market is ready for this innovation and it will undoubtedly bring huge benefits to patients in the future.”

Website-Graphics_mobile-hero_reddot
Share:

CDP ranked in the top three international design firms

Cambridge Design Partnership is recognised as one of the top three agencies in Europe and the Americas for design innovation, according to the Red Dot awards programme.

Red Dot has become established internationally as one of the most sought-after seals of quality for good design. They organise annual competitions looking to applaud the best in product design, globally.

This year Cambridge Design Partnership (CDP) came third in the ranking for design firms that continuously and progressively, produce cutting edge and forward-thinking product concepts.

“We are absolutely delighted with the news,” says Mike Cane, founding partner of CDP. “To have this sort of accolade on a global stage is really gratifying. It’s a testament to the hard work and creativity of our whole team.”

In presenting the award, Ken Koo, President of the Red Dot Award in Asia congratulated CDP and stated that the ranking recognised CDP’s continued investment in design and was a “vigorous reflection of real and sustainable design innovation capability”.

CDP was founded 23 years ago and has grown rapidly offering customer focussed technology and design innovation. Capabilities start with front end research, strategy and design, and include mechanical, electronics and software engineering as well as manufacturing and quality management. They work for market leading companies in healthcare, consumer technology and energy in Europe and US.

CDP innovations which have won coveted Red Dot Awards in recent years include the First Response Monitor, a wearable connected device which measures and broadcasts patients’ vital signs for instant analysis by medics in emergencies. Another is Klarus, a drug delivery system aimed at patients with conditions such as rheumatoid arthritis, which necessitates regular self-injection with medication.

Red Dot Design Raking

Share:

Cambridge tech company signs innovation deal with China’s design capital

In a major ceremony held in Cambridge and attended by dignitaries from both China and the UK, CDP signed what is known as a ‘Memorandum of Understanding’ (MOU) with the deputy mayor of Jiang’an district of Wuhan, Mayor Du Changhui.

This means that CDP is now set to be a lead provider of product design and innovation capabilities to companies in the new hi-tech zone in the Chinese city of Wuhan. The move is part of an economic and technological twinning programme between Cambridge and Wuhan, known as ‘Window-on-Wuhan’.

“I am delighted that CDP and the members of the Window-on-Wuhan programme have taken a step towards furthering our collaboration with companies in Wuhan,” says Mike Beadman, founding partner of CDP.

“Here at CDP we have designed many products for the Chinese market over the years. We are now looking forward to working closely with companies in Wuhan to research, develop and manufacture innovative products and technologies to meet their customer needs.”

“This is also a wonderful opportunity for our many clients to gain greater access to the Chinese market.”

The Window-on-Wuhan programme is led by Dr Simon Haworth, founder of 14 life sciences companies including Dynasty Biotechnology and Dr Richard Leaver, serial entrepreneur and partner in Boundary Capital Partners LLP. Window-on-Wuhan is supported by both the UK and Chinese governments and the new multimillion pound Sino-UK Fund.

“The aim is to establish a world-class design and engineering hub in Wuhan and establish a permanent link between Cambridge and Wuhan,’ explains Mike Beadman. ‘Wuhan holds a key strategic and economic position in China. UNESCO has awarded the city the title of ‘Capital of Design’ due to its location in the economic and geographic centre of China and its excellent infrastructure.”

At the launch event, delegation leader Minister Yan of the Wuhan Municipal Government described Window-on-Wuhan as ‘a great success’. Minister Yan introduced Wuhan to the audience, describing how the city has developed as a centre for innovation in biotech, medtech, agritech, electric vehicles and other cutting edge technologies.

George Freeman, MP, former Life Sciences Minister, gave the keynote speech at the launch ceremony, which was held in Cambridge on October 24th 2018. He said: “UK healthcare and biotech companies need a conduit to China. Match the Window-on-Wuhan programme with the funding provided by the Sino-UK Fund and we have the opportunity to power ahead.”

The Sino-UK Fund has been set up in parallel with Window-on-Wuhan programme and is a new equity investment fund to finance UK companies accessing the China market. The fund has high level team members in Cambridge, UK and Wuhan PRC: the UK team, led by partners, Simon Haworth and Richard Leaver. “The team’s network and sector knowledge will ensure that UK projects with high growth potential in China are identified, while the China team’s local execution skills will ensure that those investments achieve their potential in China,” says Mike Beadman.

“This really is a very exciting initiative and here at Cambridge Design Partnership we are sure it will create very fruitful opportunities both here and in China.”

For further information and media enquiries, please contact: media@cambridge-design.com or call 01223 264428

Share:

An innovative approach to stoma wear

22 October 2018 – Cambridge Design Partnership is delighted to be working with an innovative young designer to turn an award-winning healthcare idea into reality.

CDP will be working with industrial designer Stephanie Monty, whose family’s struggles with Crohn’s disease have led her to invent better, more beautiful, appliances for people with a stoma.

A stoma is an opening made in the abdomen, normally as a result of bowel disease, cancer or trauma. This diverts waste output into an external bag (colostomy or ileostomy bag), which the patient must wear all day, every day.

Stephanie has just won a major grant to create an ostomy product that is so attractive and empowering it can be worn openly on the beach with swimwear.

“This clever, thoughtful design will give colostomy bag wearers the choice of a product that is good-looking as well as functional,” says Wade Tipton, partner at CDP and the company’s Head of Manufacturing and Quality. “We are absolutely thrilled that Stephanie has chosen CDP to help bring this wonderful idea to fruition.”

In July 2017 Stephanie’s company, Ostique, gained significant funding from Innovate UK to take the product to market. She has chosen Cambridge Design Partnership to help her achieve that goal.

“When I met the team at CDP, I was impressed not only by their knowledge and professionalism but also by their passion and enthusiasm,” she explains.

CDP will now work with Stephanie over the next year to develop her concepts into works-like and use-like models to support user trials. Along the way we’ll create detailed requirements documents and design specifications, support Ostique’s risk management process, and develop key manufacturing methods to enable Stephanie to bring her invention to manufacture.

“We are starting with Stephanie’s design idea and helping to develop her vision based on user research” says Matt Schumann, founding partner of CDP. “Our aim is for Ostique to meet users’ needs and aspirations while fulfilling all the regulatory requirements of a Class 1 medical device and being cost-effective to manufacture.”

“Here at CDP, we plan to make a series of prototypes in our workshops to test and refine the concept further. We will then create samples for a hospital-based clinical trial under our ISO 13485 quality system.”

“Future plans could include working with Stephanie to complete the documentation package needed to meet the Government’s medical device regulations and help her develop a supply chain to take Ostique into volume manufacture.”

Stephanie, 29, was inspired to set up Ostique due to illness within her own family. “Both my father and my two younger brothers have Crohn’s Disease,” she explains. “It runs in my family and, with my own marriage planned for next year, I am also thinking of my own future children too.”

“Crohn’s is a chronic bowel disease that can lead to patients having a stoma and needing to wear a colostomy bag to catch waste outside their body. At the time I was planning my final design project at Brunel University in 2015, my brother Adam was particularly unwell and was facing the prospect of having a colostomy bag himself.”

“He was in his early 20s, in a relationship with his now wife, and of course the prospect was shocking. As I looked into what wearing a colostomy bag would mean for him, I thought to myself, there has got to be a way of improving on this design. I created the new range of innovative products myself, with designs based on the idea of a tattoo or lingerie. I would literally be baking the silicone prototypes at home in my oven.”

“This funding grant from Innovate UK is the game-changer I needed. My dream is to see Ostique on the shelves of Boots one day. I hope that people will be able to pick up a designer Ostique product along with their mascara and deodorant when they are planning a night out.”

Ostique is designed as a special-occasion appliance, particularly created for sunbathing, swimming or intimacy. It has a lower capacity than current products and can be worn for up to six hours. Stephanie first developed the idea of an innovative ostomy product in 2015 during her degree in Industrial Design and Technology at Brunel University. The silicone Ostique products are decorated with designs such as roses, lace and a skull. As well as being attractive and discreet, their functionality is improved too, with less noise during movement and enhanced deodorisation.

“I have spoken to numerous ostomates during my research and they say this product gives them hope,” says Stephanie. “Often, a colostomy bag can be a very difficult thing to come to terms with. Some people find it really difficult to be intimate with a new partner. I have spoken to one woman who had not left her house for two months since her operation, as she felt so worried and embarrassed.”

“My brother did not have to have a colostomy bag in the end but Crohn’s is a lifelong condition so the prospect never entirely goes away. There are around 200,000 people with colostomy bags in the UK and globally the numbers are rising as people get more access to health care.”

“What got me to thinking about the appearance of the design is that often, when people undergo a difficult or traumatic experience, they cheer themselves up by buying a new outfit, having a haircut or getting a tattoo. I want Ostique to be that special something for colostomy bag wearers. It looks good and they can wear one with pride, instead of having to feel embarrassed about it.”

“Ostique consists of embossed silicone covers which are reusable, paired with a disposable liner to collect the waste. The design challenges are huge, not only with the issues around adhesion to human skin but also making sure it doesn’t expand too much and become bulky and noticeable,” says Stephanie.

“We are very much looking forward to working on Ostique. It is an opportunity to treat ostomates as consumers as well as patients and an exciting innovation in healthcare,” says Wade Tipton.

“We hope to get the product ready to test by August 2019 and for it to be launching onto the market in the spring of 2020.”

CDP has a strong track record of bringing mass-use medical devices to the market. The company is a leading technology and product design partner and works with leading pharmaceutical and medical device companies around the world on their most important innovation programs.

“Our company aim is to improve lives through innovation and our work in healthcare makes a big impact,” says Wade Tipton.

Other partners in the development of Ostique are the charity Bowel & Cancer Research and University Hospital Birmingham.

For further information and media enquiries, please contact: media@cambridge-design.com or call 01223 264428

Share:

A breath of fresh air – How interactive technology could transform the patient experience in intensive care

24 September 2018 – A doctor’s experience of dealing with acute trauma on the battlefield is being used to help improve the lives of critically ill civilian patients in intensive care units (ICUs). Dr Charlotte Small and the critical care research team at the Queen Elizabeth Hospital Birmingham (QEHB) in the UK are working with technology and product design firm Cambridge Design Partnership (CDP) on a novel approach to the complex task of weaning recovering patients off ventilators.

Millions of people are admitted to ICUs around the world each year – with the majority recovering and eventually returning home. But discharge from the ICU is often not the end of the story – many patients experience significant and persistent physical, psychological or social problems. One key contributor to these issues can be the process of weaning patients off ventilator support after an extended period of chronic critical illness.

The weaning process involves various regimens of progressive reduction in mechanical support – analogous to athletic or resistance training. But, unlike athletic training, the ICU process is out of the control of patients – who may also be disorientated, confused and suffering short-term memory loss. As a result, they can be prone to distress or panic when breathing support is partially or temporarily withdrawn. As well as contributing to psychological trauma, this can lead to extended ICU stays and poorer long-term outcomes.

Now Dr Small and CDP are harnessing interactive technology in a bid to make the process more patient friendly. With funding from the National Institute for Health Research (NIHR), they are creating a ‘digital liberation from ventilation’ (DELVE) system to give patients easy-to-understand information on a screen about their breathing performance – both real time and historical – and so engage them in the weaning process. The dashboard will also enable clinicians to see at a glance a patient’s breathing performance and improve their understanding of an individual’s progress – mechanical ventilator devices currently provide no easy way of viewing historical patient data, so doctors usually piece together data from multiple sources such as vital signs monitors and clinician notes.

Loss of muscle mass whilst on mechanical ventilation is another significant challenge to patient recovery. Patients typically undergo physiotherapy sessions to rebuild body strength as soon as they are medically stable enough on the ICU. The dashboard could include a gamification element to make breathing exercises more interesting and enable patients to do them on their own – speeding up the process of building up their diaphragm muscles and relearning how to breathe for themselves.

“This novel approach has the potential to improve the patient experience – and patient outcomes – whilst preserving precious healthcare resources,” said Matt Brady, partner and head of medical therapy systems at CDP. “It’s a fantastic example of what can be achieved when human factors, design and user experience expertise are combined with electronic and software skills in a cost-effective way for the benefit of the patient and the healthcare system.”

Dr Small works in anaesthesia and pain medicine at the QEHB. Her previous role as an anaesthetic trainee in the Royal Air Force led her to undertake research and quality improvement work into the management of acute trauma-related pain. She is the chief investigator for a programme of work at the NIHR Surgical Reconstruction and Microbiology Research Centre investigating how interactive technology could benefit the experience and performance of patients during early rehabilitation in ICUs – which includes a feasibility study of the DELVE system.

“This exciting programme of work has huge potential for patients and their loved ones,” said Dr Small. “By improving understanding of the process of recovery from critical illness – and combining that with the knowledge gained from our research – we aim to enhance clinician decision making and prediction of recovery pathways. Working with the CDP development team – with its understanding of the technical aspects, as well as patient and clinician perspectives – has been crucial to bringing our ideas to life.”

The NIHR Surgical Reconstruction and Microbiology Research Centre funding the project is a partnership between the NIHR, the Ministry of Defence, University Hospitals Birmingham NHS Foundation Trust (which runs the QEHB) and the University of Birmingham. The initiative brings both military and civilian trauma surgeons and scientists together to share advanced clinical practice on the battlefield and innovation in medical research to benefit all trauma patients in the NHS at an early stage of injury.

Notes for editors
Cambridge Design Partnership is a technology and product design partner focused on helping clients grow their businesses. Some of the world’s largest companies trust CDP to develop their most important innovations. Located in both Cambridge (UK) and in Palo Alto, California (US), CDP specialises in the consumer products, healthcare, energy and industrial equipment markets. Its multidisciplinary staff have the expert knowledge to identify opportunities and tackle the challenges its clients face. For more information, visit: cambridgededev.wpenginepowered.com.

The National Institute for Health Research: improving the health and wealth of the nation through research. Established by the Department of Health and Social Care, the NIHR funds high-quality research to improve health; trains and supports health researchers; provides world-class research facilities; works with the life-sciences industry and charities to benefit all; involves patients and the public at every step. For more information, visit: www.nihr.ac.uk

The NIHR Surgical Reconstruction and Microbiology Research Centre is a national centre for trauma research, transferring innovation used in the treatment of injured military personnel to improve outcomes for all patients. It brings together the pioneering advances in surgery and infection control made by military and civilian scientists and medics working together. Launched in January 2011, the national trauma research centre will share its discoveries with the wider NHS to support delivery of excellence in a complex area of acute care. Based at the Queen Elizabeth Hospital Birmingham (QEHB), the centre harnesses expertise from the Ministry of Defence, the University of Birmingham and the QEHB and has been funded over five years with a total investment of £15 million investment. For more information, visit: www.srmrc.nihr.ac.uk

For further information, contact the marketing team:
+44 (0)1223 264428
marketing@cambridge-design.co.uk

CesarLastra
Share:

International mission to share innovation insights

Innovation leaders from technology and product design firm Cambridge Design Partnership (CDP) have just returned from a week-long trip to China where they were invited to share their expertise in using breakthrough technology to tackle real-life issues.

They were in Shanghai for the inauguration of the Shanghai International Energy Innovation Centre and to launch a report on open innovation in collaboration with non-profit organisation SHEnergy and Professor Alan Barrell, entrepreneur in residence at the Centre for Entrepreneurial Learning in Cambridge.

“In China there is no shortage of advanced technology – however, in order to really impact their bottom line and improve people’s lives, it requires an application that is based on real needs and problems worth solving,” said Cesar Lastra, consumer insight and innovation leader at CDP. “The message they were able to take away from us – and that we hope to continue to develop with them – is that true innovation happens at the intersection of consumers, technology and business.

“We also addressed the somewhat misunderstood topic of intellectual property (IP) and the perceived copycat effect in China. Part of what we do at CDP when exploring commercial opportunities and innovation strategies is to conduct IP landscaping and technology road mapping up front – before going down the path of extensive product development. That way we can reassure our clients that we are co-developing viable, protectable technology and designs from initial prototype through to launch and beyond.”

Bourn Quarters - Cambridge Design Partnership|
Share:

A new era for CDP: Cambridge Design Partnership becomes an employee-owned company for next phase of growth

21 May 2018 – Technology and product design firm Cambridge Design Partnership (CDP) has become a fully employee-owned company as it embarks on the next stage of its evolution and growth. An employee ownership trust has been set up to hold the company’s shares on behalf of its staff.

“We believe this is a great opportunity for CDP to accelerate our mission to become a world-leading innovator, with the company’s most important asset – its staff – at the centre of our strategy,” said CDP founding partners Mike Cane, Mike Beadman and Matt Schumann. “It means we can continue to grow without the involvement of external shareholders, so we can maintain full control over the direction of the business and our creative culture.”

The CDP leadership team of 10 partners will continue to manage the company and the staff will have a say in the company’s future through an elected employee council. As an employee-owned company, CDP joins the ranks of organisations such as John Lewis, which is probably the most well-known – and the UK’s largest – employee-owned business.

“We have been very successful as an owner-managed company but we believe that – to achieve our ambitious goals – we need a structure that is not only scalable but ensures our talented staff have a direct stake in the success of the business,” said Mike Cane. “Following a major strategy review last year, we realised that our team wanted to be more directly involved in the CDP story – so we decided to break away from the standard company structure.”

Earlier this year, CDP was named one of the top companies in the world-leading Cambridge technology cluster – winning the high growth award in the Cambridge News Business Excellence Awards 2018. Since it was founded by three engineers 22 years ago, the company has grown to around 120 scientists, engineers, researchers and designers in Toft near Cambridge, UK, and Palo Alto in California, US.

“Employee ownership through an employee ownership trust provides us with a stable and equitable structure that has the flexibility to scale and adapt to whatever the future brings,” said Mike Beadman. “It neatly gets around many of the unintended consequences that come with other employee ownership models. It is fundamentally more democratic and inclusive – values that resonate with the CDP creative culture.”

Over the last three years, CDP has expanded its capabilities significantly to make it a ‘one-stop shop’ for businesses in the healthcare and consumer sectors that need to innovate and launch their next-generation products quickly. While its strength has traditionally been in technology and engineering design, it now also has strong teams working at the front end of innovation – helping clients optimise their innovation plans – and at the back end, where its manufacturing engineering group sets up new processes and multinational supply chains.

“Partnership has always been in our name – and now it means even more,” said Matt Schumann. “Every member of staff, in every interaction with our customers, will be fully invested in the success of their project. Working together, with our goals aligned, we believe is the best environment for innovation to occur.”

Notes for editors

Cambridge Design Partnership is a technology and product design partner focused on helping clients grow their businesses. Some of the world’s largest companies trust CDP to develop their most important innovations. Located in both Cambridge (UK) and in Palo Alto, California (US), CDP specialises in the consumer products, healthcare, energy and industrial equipment markets. Its multidisciplinary staff have the expert knowledge to identify opportunities and tackle the challenges its clients face. For more information, visit: www.cambridge-design.co.uk

For further information, contact the marketing team:
+44 (0)1223 264428
marketing@cambridge-design.co.uk

Image
Share:

CDP wins business excellence award

Technology and product design firm Cambridge Design Partnership (CDP) has been named one of the top companies in the world-leading Cambridge technology cluster. It has won the high growth award in the Cambridge News Business Excellence Awards 2018.

The judges heard how the company – founded by three engineers more than 20 years ago – has now grown to around 120 researchers, designers, scientists and engineers. In the last financial year, sales increased by more than 35% – with particular growth in US sales – and the firm has an increasing number of loyal clients who choose it as their innovation partner year after year.

Over the last three years, CDP has expanded its capabilities significantly to make it a ‘one-stop shop’ for businesses that need to innovate and launch their next-generation products quickly. While its strength has traditionally been in engineering development and product design, it now also has strong teams working at the front end of innovation – helping clients optimise their innovation plans – and at the back end, where its manufacturing engineering group sets up new processes and multinational supply chains.

The company undertakes fast-track, customer-focused innovation programmes using its proven ‘Potential Realised’ framework to optimise the return on clients’ investment in innovation.

CDP founder Mike Cane said: “Our success is the result of a lot of hard work and commitment from our talented team and loyal clients – and winning this title is a fitting recognition of their achievements.

“Our clients range from small, innovative start-ups to giant multinational organisations. And our product developments range from connected medical devices and diagnostic equipment to consumer products and manufacturing solutions. But, at the end of the day, we believe product development is all about people.

“What sets us apart is our focus on the user – we work on the basis of ‘market pull’ rather than the usual ‘technology push’. We never lose sight of the fact that products are for customers – the technology is only there to make something do what it’s supposed to do at the right cost. We work from the customer’s perspective. Our aim is to significantly improve people’s lives through innovation.”

Share:
Find the authors
on LinkedIn:

How AI can help improve sports performance

I wonder how many athletes in the Winter Olympics had used artificial intelligence (AI) to improve their performance. AI is when a computer is programmed to mimic human cognitive functions such as learning and problem solving. With wearables like Fitbit abounding in the sports market, AI is beginning to play a key role in allowing these devices to provide a ‘quantified self’ – useful statistics derived from performance measurements that allow athletes to improve their training, and therefore their performance.

Let’s take tennis as an example – often athletes will need a coach to give them direction on how to improve their form, and to spot mistakes and inefficiencies while watching a game. Coaches typically set targets and goals by making judgements based on what they can see. Wearables can provide insightful data on previously undetectable metrics to coaches, through readings such as heart rate and movement. Wearables contain electronic sensors, such as accelerometers or gyroscopes, which provide continuous movement information that shows variations when different events occur. For example, a wrist-worn device will read different movement patterns for a forehand shot, compared with a backhand equivalent.

Readings from wearables will be affected by many factors, such as the way the person is holding a racket, what serve or shot they’re doing or even how the device is being worn. That’s just a fraction of the many things that could change, and these variables all need to be considered to find out how the measurements match up to events.

In conventional approaches, computers use signal processing to find events in the incoming readings. The computer software needs to be programmed with various filters and transformations to apply to these readings, and these are used to detect specific, consistent events that may be occurring. However, with sporting data, it’s hard to predict what each event looks like because events rarely involve the exact same movement as there are so many factors that could change. This reduces the accuracy of the device, which isn’t ideal.

Machine learning – an area of AI – can help. Machine learning allows software to learn from incoming readings and to identify factors that affect the measurements. This allows software to decide which events are occurring in given measurements and to get better with more data over time. For example, with tennis data, machine learning can detect similar movement patterns and group similar data together – in effect, it creates movement classifications by itself for events like serves, and shots (e.g. forehand, backhand, volleys). AI lets us process vast amounts of statistical data with less effort than ever – and can even identify factors affecting sports performance that are impossible for us humans to detect.

Although machine learning can be effective, it brings its own set of challenges. AI can never be 100% accurate without vast quantities of training data. We’re talking about hundreds of thousands of readings – and it’s not easy to collect this much data manually! Luckily, it’s possible to start with a smaller amount of data and gradually train the machine learning models with more data over time to improve accuracy.

By processing wearable sensor readings using AI, valuable metrics that were previously difficult to gather can be obtained. By combining this data with powerful smartphone apps, athletes can be provided with actionable insights and coaching, which in turn improves performance and helps athletes to achieve their best.

Our in-house software experts here at Cambridge Design Partnership have delivered successful implementations of AI to many of our clients. Just think what AI could do for your business…

MDD render 2
Share:

DELIVERING PEACE OF MIND A novel approach to drug delivery from CDP is set to transform the patient experience

18 October 2017 – Help is on the horizon for patients juggling complicated treatment regimens for chronic diseases such as rheumatoid arthritis (RA). A novel approach to drug delivery from technology and product design firm Cambridge Design Partnership (CDP) is paving the way for a new generation of treatment that is easier for patients and cost effective for healthcare providers.

Klarus is set to transform the world of auto-injectors – doing away with the need for RA patients to worry about storing their drugs in the fridge, warming them up to the correct temperature for injection, preparing their auto-injector for use and disposing of the device safely. Klarus does everything for them – they simply have to pick up the reusable auto-injector from its base station when prompted to do so, inject themselves and then return the device to its cradle.

“It’s the Nespresso of auto-injectors,” said Uri Baruch, head of drug delivery at CDP. “Klarus will store drugs at the correct temperature and warm them up when required – minimising the pain of injecting cold medication. It will then prepare the auto-injector with the correct needle and medication cartridge, and prompt the patient to take their drug.

“After injection, Klarus will collect the needle and cartridge ready for safe disposal – alerting the patient when supplies are running low, and reordering if required. The base station technology could be adapted to cope with multiple users and different medications – either in the home or at a small clinic, for example. It uses fingerprint recognition technology to identify the correct user each time and a childproof lock to prevent accidental use.”

As well as RA, Klarus could be used to treat diseases such as multiple sclerosis or to administer vaccines. It could also enable some cancer patients to be treated at home using drugs that are currently only allowed to be given in hospital. And it opens the door to the emerging world of companion diagnostics and truly personalised medication, where treatment is tailored to each individual patient using genetic information.

“All too often, patients with a chronic disease face the additional burden of struggling with a complex treatment regimen at home,” said Uri. “Learning how to use a new drug delivery device and remembering multiple treatment steps can be challenging – particularly for the elderly or those with dexterity issues. That’s one of the reasons why adherence rates are often low – many patients just give up or fail to take their medication correctly.

“Our Klarus system alleviates that burden for the patient and helps ensure they get the full benefit from their treatment. It automates many of the use steps commonly missed or not carried out by patients – such as checking the use-by date or remembering to inject when following an irregular therapy schedule. We’ve used state-of-the-art technology and applied our user experience and human factors expertise – together with our knowledge of medical device regulation and our skills in electronics, mechanical engineering, software and connectivity – to create a radically new approach to drug delivery.”

The Klarus system could be offered to patients as a subscription-based service. It is expected to cost healthcare providers less than $1,000 per system, and the cartridges would be around $2 each. So Klarus would pay for itself in the space of just one year if, for example, a patient was having weekly injections for RA at a typical cost of $10 per single-use auto-injector. As well as helping to improve patient outcomes, it would also be more environmentally friendly – saving on packaging and involving the disposal of only a small cartridge each time, rather than an entire auto-injector.

Uri will be talking about the Klarus system in track B of the drug delivery technology presentations on 19 October at the Partnerships in Drug Delivery event in Boston, US. The CDP team will also be showcasing Klarus at PDA’s Universe of Pre-filled Syringes and Injection Devices event, 7-8 November, at the Austria Center Vienna, stand X92.

Notes for editors

Cambridge Design Partnership is a technology and product design partner focused on helping clients grow their businesses. Some of the world’s largest companies trust CDP to develop their most important innovations. Located in both Cambridge (UK) and in Palo Alto, California (US), CDP specialises in the consumer products, healthcare, energy and industrial equipment markets. Its multidisciplinary staff have the expert knowledge to identify opportunities and tackle the challenges its clients face. For more information, visit: www.cambridge-design.co.uk

For further information, contact the marketing team:
+44 (0)1223 264428
marketing@cambridge-design.co.uk